Fact.MR – A Market Research and Competitive Intelligence Provider: According to Fact.MR’s analysis, The Demand for Blood Collection Tubes For Liquid Biopsy will expand at an impressive CAGR of around 12% from 2021 to 2031.
Technological advances have increased the diversity of blood collection tubes for liquid biopsy applications.
Fact.MR – A Market Research and Competitive Intelligence Provider: According to Fact.MR’s analysis, The Demand for Blood Collection Tubes For Liquid Biopsy will expand at an impressive CAGR of around 12% from 2021 to 2031.
Rising advancements in the field of biotechnology have enabled the establishment of several non-invasive approaches for disease diagnosis. Increasing surgical procedures across the world is creating huge opportunity for revenue growth of the blood collection tubes market.
According to a UN report, the geriatric population in 2019 was 702.9 Mn, with Eastern and South-Eastern Asia having the highest numbers, followed by Europe and North America. This huge rise in the geriatric population is leading to a rise in the number of surgeries, thereby catalysing demand for blood collection tubes for liquid biopsy.
Request a report sample to gain compressive insights at
https://www.factmr.com/connectus/sample?flag=S&rep_id=4495
Key Takeaways from Market Study
- ccfDNA isolation kits are anticipated to gain maximum revenue share over the forecast period, and the segment is projected to expand at a CAGR of 10.5% during the forecast period.
- By material, the plastic segment is expected to hold a share of 68% in 2020, and expand at a significant CAGR of around 15% through 2030.
- By application, the IVD segment is expected to hold maximum revenue share of 73.4% in 2020.
- Among the end users, genetic diagnostic labs were the dominant segment in in 2020.
- The market in China is expected to surge ahead at a mammoth CAGR of over 22% from 2020 to 2030.
- Europe and North America are leading regions in the global blood collection tubes for liquid biopsy market, with a revenue share of approximately 76%. The COVID-19 pandemic has had a slight adverse impact on the market, majorly due to halt in research & development activities across the globe.
“Increasing research & development activities are expected to boost demand for blood collection tubes for liquid biopsy. On the other hand, there is rising population of cancer patients, and therefore, requirement for highly sensitive and precise diagnostic for better treatment solutions is increasing,” says a Fact.MR analyst.
Ask Your Blood Collection Tubes For Liquid Biopsy Market Related Questions & Get Customized Reports
https://www.factmr.com/connectus/sample?flag=RC&rep_id=4495
Competitive Landscape
Key market players covered by Fact.MR in the report are is Roche, Streck, Preanalytix, Norgen Biotek, Biocept, Biomatrica, and INVITEK MOLECULAR GMBH (NUVISAN GmbH/STRATEC GROUP). Strategies adopted by these key players for global expansion are largely product launches and mergers & acquisitions. There have been a few strategic partnerships among leading players to enhance the supply chain and logistics.
- For instance, in July 2018, Diversigen Incand and Norgen Biotek Corp. announced that they have entered into a strategic partnership, through which, industry and academic researchers will benefit from comprehensive end-to-end logistical, sequencing, and analytical solutions, to meet the growing need for microbiome analyses.
Also, there have been collaborations among leading players to gain FDA approval of products.
- For example, in January 2020, Biodesix, Inc. and Streck, Inc. announced a Regulatory Cooperation Agreement that will further enable both companies in their pursuit of FDA approval for diagnostic testing services and specimen collection products.
More Insights on the Global Blood Collection Tubes for Liquid Biopsy Sales Outlook
Fact.MR provides an incisive coverage on global blood collection tubes for liquid biopsy market, presenting historical demand data (2015-2019) and forecast statistics for the period from 2021-2031. The study divulges compelling insights on the global demand for Blood Collection Tubes for Liquid Biopsy with a detailed segmentation on the basis of
·Product
- ccfDNA Tubes
- ccfDNA Isolation Kits
- cfRNA Tubes
- ccfRNA Isolation Kits
- CTC Tubes
- gDNA Tubes
- gDNA Isolation Kits
- Intracellular RNA Tubes
- Intracellular RNA Kits
- NIPT
·Material
- Glass
- Plastic
·Application
- IVD
- Research
· End User
- R&D centres
- Genetic Diagnostic Labs
- Conventional Diagnostic Centres
·Region
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- MEA
The report covers following Blood Collection Tubes for Liquid Biopsy Market insights and assessment that are helpful for all participants involved in the Blood Collection Tubes for Liquid Biopsy market:
- Data on recently introduced regulations and their impact on key industries and on demand in Blood Collection Tubes for Liquid Biopsy
- Latest industry Analysis on Blood Collection Tubes for Liquid Biopsy Market, with key analysis of market drivers, trends, and influencing factors
- Changing Blood Collection Tubes for Liquid Biopsy demand and consumption of diverse products
- Major trends underlining funding by key investors in numerous countries
- New investment opportunities in diverse technology and product or service types
- Comprehensive data and Competitive analysis of Blood Collection Tubes for Liquid Biopsy major players
- Blood Collection Tubes for Liquid Biopsy Market sales in US will grow at a steady pace, driven by growing consumer confidence and economic recovery
- Blood Collection Tubes for Liquid Biopsy demand forecast in Europe remains stable, as many countries such as UK, France, and Germany focus on boosting growth
Explore Fact.MR’s Coverage on the Healthcare Domain
- Tissue Expanders Market - Increasing demand for scalp and forehead skin reconstruction due to skin differentiation is predicted to drive the global tissue expanders market forward throughout the forecast period. Tissue expander sales will continue to rise due to a growing preference for reconstruction treatments over skin implants or grafts.
- Extremities Reconstruction Market - Improvements in healthcare infrastructure are also projected to drive market expansion. Unfavorable reimbursement policies, as well as complications related to extremities reconstruction surgery, are projected to stymie market expansion. The market for extremities reconstruction in North America is expected to grow at the quickest rate.
- Angioplasty Balloons Market - North America and Europe account for the majority of the overall revenue generated by the global angioplasty balloons market. This is due to rising awareness of treatment alternatives and general health awareness in these areas, as well as the influence of rising prevalence of linked ailments.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology to even the most niche categories. 80% of Fortune 1000’s trust us in critical decision making.
MarketNgage is powered by Fact.MR – our Unified Intelligence Engine, a revolutionary Market Research Subscription platform with a flexible pricing to suit your needs.
You can access all our healthcare research reports by signing up with MarketNgage’s Market Research Subscription with FREE credits. MarketNgage is powered by Fact.MR – A Fully integrated research solution for seamless single-window access Widest coverage on emerging markets, nascent products, and disruptive technologies.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com